Previous 10 | Next 10 |
2023-10-04 21:46:29 ET Summary DaVita Inc. stock has been heavily sold in '23, trading below its 50-day moving average for the past 8 weeks. The company lacks economic value, and its reinvestment runway looks limited, producing sub-standard returns on capital. The market expec...
2023-09-16 08:26:36 ET Summary The sector as a whole is overvalued by about 15% relative to 11-year averages. Healthcare providers and pharmaceuticals/biotechnology look fairly valued, whereas healthcare equipment is the less attractive subsector. IXJ: a global alternative to ...
DaVita launches community health tour to provide free kidney screenings and education coast-to-coast PR Newswire Kidney care provider invests in early detection and prevention to help reduce progression of chronic kidney disease in key communities it serves DENVER , ...
DaVita and Adtalem collaborate to address growing nephrology nursing shortage PR Newswire Collaboration includes launch of new nursing curriculum that increases access to career pathways post-graduation DENVER , Sept. 12, 2023 /PRNewswire/ -- DaVita Inc...
DaVita Inc. to Participate in Fireside Chat with UBS PR Newswire DENVER , Sept. 11, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman , and its group vice president of investor relations, Nic...
2023-08-15 16:57:12 ET Billionaire Larry Robbins' Glenview Capital Management in Q2 2023 exited its stakes in Chinese e-commerce giant Alibaba ( NYSE: BABA ) and Google-parent Alphabet ( NASDAQ: GOOG ) ( NASDAQ: GOOGL ), while picking up new positions in IT serv...
2023-08-15 03:59:00 ET Summary Berkshire Hathaway's 13F stock portfolio value increased from ~$325B to ~$348B in Q2 2023. The top five positions in the portfolio are Apple Inc., Bank of America, American Express, Coca-Cola, and Chevron. Berkshire Hathaway repurchased ~3.92M Cl...
2023-08-14 08:15:00 ET Summary This article provides a dashboard with industry metrics in healthcare, then focus on the Global X Genomics & Biotechnology ETF. Pharmaceuticals/biotechnology and healthcare providers have fair value and quality scores. Healthcare equipment is...
2023-08-07 15:04:56 ET More on DaVita DaVita Inc. ( DVA ) Q2 2023 Earnings Call Transcript DaVita: Breakout Not Supported Without Leverage Effects, Reiterate Hold DaVita: A Strong Earnings Beat, Better Free Cash Flow Outlook, Upgrading To Buy DaVita, Fres...
2023-08-03 21:00:22 ET Image source: The Motley Fool. DaVita (NYSE: DVA) Q2 2023 Earnings Call Aug 03, 2023 , 5:00 p.m. ET Operator Continue reading For further details see: DaVita (DVA) Q2 2023 Earnings Call Transcript
News, Short Squeeze, Breakout and More Instantly...
DaVita Inc. Schedules 2nd Quarter 2024 Investor Conference Call PR Newswire DENVER , July 18, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, Aug...
2024-06-21 02:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...